RecruitingNot ApplicableNCT07071207
Effect of Text Message Reminders on M-ISI Score After Prostate Surgery
Effect of Text Message Reminders on Michigan Incontinence Symptom Index Score After Prostate Surgery
Sponsor
University of Rochester
Enrollment
132 participants
Start Date
Sep 15, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to compare post-prostatectomy incontinence via Michigan Incontinence Score Index in patients receiving daily text message reminders for pelvic floor exercises when compared to those not receiving text reminders.
Eligibility
Sex: MALEMin Age: 18 Years
Inclusion Criteria7
- Planning to undergo a radical prostatectomy (RALP) or laser enucleation of the prostate (LEP) procedure
- Patient of URMC Urology
- Adult male 18 years of age and older
- Able to read, write, and speak in English (NOTE: due to limitations with questionnaire validation, only English-speaking subjects are permitted)
- Has access to a mobile device capable of receiving automated text messages.
- Willing to receive text messages and to complete questionnaires via SMS text.
- Willingness to participate and able to provide informed consent.
Exclusion Criteria6
- Less than 18 years of age
- Unable to send and receive SMS texts
- Unable to read, write, and speak English
- Catheter dependency
- Has or plans to have Artificial Urinary Sphincter or Urethral Sling during the study period
- In the opinion of the investigator, the subject has a history or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the study, interfere with the subject's participation for the full duration of the study, or is not in the best interest of the subject to participate.
Interventions
BEHAVIORALText message reminders
daily 8am text messages reminding patients to perform Kegel exercises as per their standard-of-care post-operative discharge instructions.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07071207
Related Trials
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
NCT070271241 location
Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program
NCT0489583916 locations
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
NCT0697084728 locations
Mechanisms of Resistance to PSMA Radioligand Therapy
NCT054354953 locations
INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis
NCT073986901 location